CEFTAZIDIME MEVON POWDER FOR SOLUTION FOR INJECTION OR INFUSION 1G/ VIAL
Product details
Registration number: SIN14738P
Classification: Prescription Only
Active ingredients: Ceftazidime pentahydrate 1.164g equivalent to ceftazidime
Strength: 1.0g/ vial
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAVENOUS; INTRAMUSCULAR
Registrant: NOVEM PHARMA PRIVATE LIMITED
ATC code: J01DD02
HSA approval date: 27 February 2015
Manufacturer(s): Sinopharm Zhijun (Shenzhen) Pharmaceutical Co., Ltd
Manufacturing country/countries: CHINA
What are the HSA registration number and classification for CEFTAZIDIME MEVON POWDER FOR SOLUTION FOR INJECTION OR INFUSION 1G/ VIAL?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN14738P
Classification: Prescription Only
What active ingredients and strength are recorded for CEFTAZIDIME MEVON POWDER FOR SOLUTION FOR INJECTION OR INFUSION 1G/ VIAL?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Ceftazidime pentahydrate 1.164g equivalent to ceftazidime
Strength: 1.0g/ vial
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for CEFTAZIDIME MEVON POWDER FOR SOLUTION FOR INJECTION OR INFUSION 1G/ VIAL?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAVENOUS; INTRAMUSCULAR
Who is the recorded registrant for CEFTAZIDIME MEVON POWDER FOR SOLUTION FOR INJECTION OR INFUSION 1G/ VIAL?
According to the HSA dataset updated 7 August 2026:
Registrant: NOVEM PHARMA PRIVATE LIMITED
Which manufacturers and countries are listed for CEFTAZIDIME MEVON POWDER FOR SOLUTION FOR INJECTION OR INFUSION 1G/ VIAL?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Sinopharm Zhijun (Shenzhen) Pharmaceutical Co., Ltd
Manufacturing country/countries: CHINA
Where can I look up CEFTAZIDIME MEVON POWDER FOR SOLUTION FOR INJECTION OR INFUSION 1G/ VIAL in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN14738P or the exact product name CEFTAZIDIME MEVON POWDER FOR SOLUTION FOR INJECTION OR INFUSION 1G/ VIAL. The general register link does not preselect this product.
What are the source dates for this CEFTAZIDIME MEVON POWDER FOR SOLUTION FOR INJECTION OR INFUSION 1G/ VIAL record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this CEFTAZIDIME MEVON POWDER FOR SOLUTION FOR INJECTION OR INFUSION 1G/ VIAL record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN14738P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)